PTC Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. SMCI
8. RTX
9. S
10. COF

Go back to PTC Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update

PTC Therapeutics (PTCT) Posts Smaller-than-Expected Q2 Loss on Much Higher Revs; Raises Outlook

August 8, 2017 4:51 PM EDT

PTC Therapeutics (NASDAQ: PTCT) reported Q2 EPS of ($0.44), $0.84 better than the analyst estimate of ($1.28). Revenue for the quarter came in at $45.8 million versus the consensus estimate of $28.78 million.

2017 Guidance:

Translarna net sales for 2017 are now anticipated to be between $120 and $140 million,... More